BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19277037)

  • 21. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.
    Warren LEG; Chen YH; Halasz LM; Brock JE; Capuco A; Punglia RS; Wong JS; Golshan M; Bellon JR
    Breast Cancer Res Treat; 2019 Dec; 178(3):607-615. PubMed ID: 31493031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Gennaro M; De Santis MC; Mariani L; Lo Vullo S; Cappelletti V; Agresti R; Cortinovis U; Paolini B; Di Cosimo S; Carcangiu ML; Daidone MG; Lozza L
    Breast; 2017 Oct; 35():63-68. PubMed ID: 28651115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy.
    Epstein AH; Connolly JL; Gelman R; Schnitt SJ; Silver B; Boyages J; Rose MA; Recht A; Harris JR
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):755-60. PubMed ID: 2550399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of age in the outcome and treatment of older women with ductal carcinoma in situ.
    Ho A; Goenka A; Ishill N; Van Zee K; McLane A; Gonzales AM; Tan L; Cody H; Powell S; McCormick B
    Breast; 2011 Feb; 20(1):71-7. PubMed ID: 20739181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
    Cho WK; Choi DH; Park W; Kim H; Cha H
    Breast; 2019 Oct; 47():16-21. PubMed ID: 31265973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
    Vicini FA; Recht A
    J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
    Faverly DR; Hendriks JH; Holland R
    Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the treatment of ductal carcinoma in situ of the breast.
    Baxter NN; Virnig BA; Durham SB; Tuttle TM
    J Natl Cancer Inst; 2004 Mar; 96(6):443-8. PubMed ID: 15026469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical ductal carcinoma in situ of the breast: treatment with conservative surgery and radiotherapy.
    Amichetti M; Caffo O; Richetti A; Zini G; Rigon A; Antonello M; Roncadin M; Coghetto F; Valdagni R; Fasan S; Maluta S; Di Marco A; Neri S; Vidali C; Panizzoni G; Aristei C
    Tumori; 1999; 85(6):488-93. PubMed ID: 10774571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current controversies in the treatment of ductal carcinoma in situ of the breast.
    Franceschini G; Terribile D; Magno S; Fabbri C; D'Alba P; Chiesa F; Di Leone A; Scafetta I; Masetti R
    Ann Ital Chir; 2008; 79(3):151-5. PubMed ID: 18958961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation Therapy Following Breast Conserving Surgery for Ductal Carcinoma in situ: Yes or No?
    Stoleru LS; Stoleru S
    Chirurgia (Bucur); 2017; 112(4):403-412. PubMed ID: 28862116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    ; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
    J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
    Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
    Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.